Table 1.
GE-GTCS | TLE-HS | HC | |
---|---|---|---|
(n = 96) | (n = 107, L/R = 53/54) | (n = 65) | |
Sex (M/F) | 65/31 | 60/47 | 40/25 |
Age (years) | 25.65 ± 7.85 | 27.29 ± 7.81 | 24.98 ± 4.96 |
(16–50) | (16–48) | (21–40) | |
Onset (years) | 19.72 ± 8.86 | 16.28 ± 9.15 | — |
(7–49) | (0.25–43) | ||
Duration (years) | 5.93 ± 6.36 | 10.87 ± 8.76 | — |
(0.01–43) | (0.08–32) | ||
Seizure frequency | 2.82 ± 9.86 | 9.69 ± 22.69 | — |
(per month) | (0.01–62) | (0.03–150) | |
Drug resistant (%) | 13 (13.5%) | 40 (37.4%) | — |
L LTLE-HS, R RTLE-HS, M male, F female.